Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05001880
Title Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

peritoneal mesothelioma


Bevacizumab + Carboplatin + Pemetrexed Disodium

Atezolizumab + Bevacizumab + Carboplatin + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.